Ami Organics Ltd
NSE:AMIORG

Watchlist Manager
Ami Organics Ltd Logo
Ami Organics Ltd
NSE:AMIORG
Watchlist
Price: 2 299.3501 INR 7.6%
Market Cap: 94.1B INR
Have any thoughts about
Ami Organics Ltd?
Write Note

Ami Organics Ltd
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Ami Organics Ltd
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Ami Organics Ltd
NSE:AMIORG
Cash from Operating Activities
â‚ą1.3B
CAGR 3-Years
66%
CAGR 5-Years
53%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Cash from Operating Activities
â‚ą34.1B
CAGR 3-Years
26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Cash from Operating Activities
â‚ą45B
CAGR 3-Years
7%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Cash from Operating Activities
â‚ą127.2B
CAGR 3-Years
16%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Cash from Operating Activities
â‚ą34.1B
CAGR 3-Years
24%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
Mankind Pharma Ltd
NSE:MANKIND
Cash from Operating Activities
â‚ą21.5B
CAGR 3-Years
24%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Ami Organics Ltd
Glance View

Market Cap
94.1B INR
Industry
Pharmaceuticals

Ami Organics Ltd. engages in the development and commercialization of pharmaceutical intermediate products. The company is headquartered in Surat, Gujarat and currently employs 561 full-time employees. The company went IPO on 2021-09-14. These specialty chemicals with varied end usage, focus on the development and manufacturing of pharma intermediates for regulated and generic active pharmaceutical ingredient (APIs) and new chemical entity (NCEs). The company manufactures pharma intermediates for certain APIs, including dolutegravir, trazodone, entacapone, nintedanib and rivaroxaban. The pharma intermediates, which the Company manufactures have application in certain high-growth therapeutic areas, including anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant and anti-coagulant. The company has developed and commercialized over 450 pharma intermediates for APIs and NCEs across 17 therapeutic areas. Its specialty chemicals have applications in the agrochemicals and fine chemicals industries. The firm supplies its products to more than 150 customers directly in India.

AMIORG Intrinsic Value
1 495.0963 INR
Overvaluation 35%
Intrinsic Value
Price

See Also

What is Ami Organics Ltd's Cash from Operating Activities?
Cash from Operating Activities
1.3B INR

Based on the financial report for Mar 31, 2024, Ami Organics Ltd's Cash from Operating Activities amounts to 1.3B INR.

What is Ami Organics Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
53%

Over the last year, the Cash from Operating Activities growth was 91%. The average annual Cash from Operating Activities growth rates for Ami Organics Ltd have been 66% over the past three years , 53% over the past five years .

Back to Top